Bionpharma Inc. Receives USFDA Approval for Etravirine Tablets Developed in Collaboration with STEERLife
Jointly developed HIV-1 therapy leverages STEERLife’s proprietary solvent-free FragMelt(TM) continuous processing platform to address complex formulation challenges Marking a significant milestone in the global effort to expand access to advanced HIV therapies, STEERLife (the life sciences division of STEER World), and Bionpharma Inc. today announced that Bionpharma has received Abbreviated New Drug Application (ANDA) approval […]